2017 Industry Partner of the Year: IDB Holland bv
IDB Holland bv is a Health Canada authorized supplier of Lutetium-177 (Lu-177). Lu-177 is a nuclear medicine treatment used to improve the quality of life in patients with neuroendocrine cancer. Lawson collaborated with IDB Holland bv in a clinical trial called “An Open Label Phase II, Registry...